Filing Details

Accession Number:
0001082038-20-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-05 20:33:19
Reporting Period:
2020-06-03
Accepted Time:
2020-06-05 20:33:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1082038 Durect Corp DRRX Pharmaceutical Preparations (2834) 943297098
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1604753 R Judy Joice 10260 Bubb Road
Cupertino CA 95014
Sr. Vp Operations & Corp Qa No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-03 34,864 $0.78 67,611 No 4 M Direct
Common Stock Disposition 2020-06-03 34,864 $2.45 32,747 No 4 S Direct
Common Stock Acquisiton 2020-06-03 22,956 $0.78 55,703 No 4 M Direct
Common Stock Disposition 2020-06-03 22,956 $2.45 32,747 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-06-03 34,864 $0.00 34,864 $0.78
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-06-03 22,956 $0.00 22,956 $0.78
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
22,956 2012-05-03 2022-02-03 No 4 M Direct
0 2012-02-03 2022-02-03 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.415 to 2.50, inclusive. The reporting person undertakes to provide to Durect Corporation, any security holder of Durect Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  2. Number of shares beneficially owned which were acquired by the reporting person under Durect's Employee Stock Purchase Plan between 11/01/2007 to 06/03/2020.
  3. This option vested in full on 02/03/2016.
  4. This option vested in full on 02/03/2012.